Showing results (681-690 of 878) with videos related to
Sort By:
Pageof 88
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|April 23, 2015
Comparison of Nutrition Profile and Diet Record Between Veteran and Nonveteran End-Stage Renal Disease Patients Receiving Hemodialysis in Veterans Affairs and Community Clinics in Metropolitan South-Central TexasSue E D Cunningham, Darlene Verkaik, Georgiana Gross, et al.ESMO Open|November 3, 2022
CXD101 and nivolumab in patients with metastatic microsatellite-stable colorectal cancer (CAROSELL): a multicentre, open-label, single-arm, phase II trialM P Saunders, J Graham, D Cunningham, et al.Women'S Health Issues : Official Publication of the Jacobs Institute of Women'S Health|November 7, 2015
Exploring Group Composition among Young, Urban Women of Color in Prenatal Care: Implications for Satisfaction, Engagement, and Group AttendanceValerie A Earnshaw, Lisa Rosenthal, Shayna D Cunningham, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancerP Ross, A Norman, D Cunningham, et al.Clinical Radiology|July 4, 2021
Chronic lymphocytic leukaemia and Richter's transformation: multimodal review and new imaging paradigmsE Musanhu, R K Sharma, A Attygalle, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
ZD1694: A novel thymidylate synthase inhibitor with substantial activity in the treatment of patients with advanced colorectal cancer. Tomudex Colorectal Study GroupJ R Zalcberg, D Cunningham, E Van Cutsem, et al.European Journal of Cancer & Clinical Oncology|August 1, 1983
A randomised multicentre single blind comparison of a cannabinoid anti-emetic (levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapyA W Hutcheon, J B Palmer, M Soukop, et al.Blood|November 1, 1993
A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapyP L Amlot, M J Stone, D Cunningham, et al.Cancer Chemotherapy and Pharmacology|December 24, 2008
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapyAlexandra Leary, L Assersohn, D Cunningham, et al.World Neurosurgery|December 15, 2016
Rare Lesions of the Internal Auditory CanalKentaro Watanabe, Mary In-Ping Huang Cobb, Ali R Zomorodi, et al.Pageof 88